– SIFI recibe opinión positiva de COMP sobre la designación de medicamento huérfano para la polihexanida en el tratamiento de la queratitis fúngica ACI SANT ‘ ANTONIO, Italia, 22 de julio de 2024 /PRNewswire/ — SIFI, una empresa oftálmica líder a nivel internacional con sede en Italia,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.